Associated Papers
The constitutive oncogenic and signaling activities of phosphatidylinositol 3-kinase (PI3K) isoforms p110β and p110δ.
Ito Y et al.
Biorxiv : the Preprint Server for Biology, 2025
Clinical, Immunological, and Genetic Features in Patients with Activated PI3Kδ Syndrome (APDS): a Systematic Review.
Jamee M et al.
Clinical Reviews in Allergy & Immunology, 2020
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients.
Chen L et al.
Nature Communications, 2018
Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.
Dornan GL et al.
Frontiers in Immunology, 2018
Conformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1.
Dornan GL et al.
Proceedings of the National Academy of Sciences of the United States of America, 2017
Primary Immunodeficiencies Associated with EBV Disease.
Cohen JI
Current Topics in Microbiology and Immunology, 2015
Phosphatidylinositol-3-kinase α catalytic subunit gene somatic mutations in bronchopulmonary neuroendocrine tumours.
Capodanno A et al.
Oncology Reports, 2012
Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.
Ellis MJ et al.
Breast Cancer Research and Treatment, 2010
Activated PI3K-delta syndrome in an Egyptian pediatric cohort with primary immune deficiency.
Ahmed AA et al.
Allergologia Et Immunopathologia, 0
Select a paper to view details